CRISIL Issues Monitoring Agency Report for Molbio Diagnostics' IPO Proceeds
Molbio Diagnostics Ltd 路 Others (Uncategorized) 路 07 Nov 2026, 1:35 am
CRISIL Issues Monitoring Agency Report for Molbio Diagnostics' IPO Proceeds CRISIL Ratings released the Monitoring Agency Report for Molbio Diagnostics for the quarter ended 30th Sep'26, reporting zero deviation in the utilization of IPO proceeds. Out of the gross proceeds of Rs 2,000.00 million (net proceeds of Rs 1,872.81 million), the company utilized Rs 67.96 million toward plant, machinery, and equipment procurement across Goa and Visakhapatnam units. The remaining unutilized amount of Rs 1,932.04 million is securely deployed across bank fixed deposits (Rs 1,650.00 million), the monitoring account (Rs 154.85 million), and the public issue account.
Original exchange filing (PDF)
More announcements from Molbio Diagnostics Ltd
- Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026 路 11 Nov 2026
- Audio Recording of Earnings call held on November 05,2026 for the quarter and half year ended September 30,2026. 路 06 Nov 2026
- Outcome of Board meeting held on Thursday, November 05, 2026 路 06 Nov 2026
- Investor presentation 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. 路 05 Nov 2026
- To consider and approve the Unaudited financial results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026 路 05 Nov 2026
